- Home
- MED vs MCRB Comparison
MED vs MCRB Comparison
Compare MED & MCRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MED
- MCRB
- Stock Information
- Founded
- MED 1980
- MCRB 2010
- Country
- MED United States
- MCRB United States
- Employees
- MED N/A
- MCRB N/A
- Industry
- MED Packaged Foods
- MCRB Biotechnology: Pharmaceutical Preparations
- Sector
- MED Consumer Staples
- MCRB Health Care
- Exchange
- MED Nasdaq
- MCRB Nasdaq
- Market Cap
- MED 156.7M
- MCRB 141.9M
- IPO Year
- MED N/A
- MCRB 2015
- Fundamental
- Price
- MED $13.05
- MCRB $0.69
- Analyst Decision
- MED Hold
- MCRB Hold
- Analyst Count
- MED 1
- MCRB 5
- Target Price
- MED $16.50
- MCRB $4.00
- AVG Volume (30 Days)
- MED 206.1K
- MCRB 793.6K
- Earning Date
- MED 04-28-2025
- MCRB 03-13-2025
- Dividend Yield
- MED N/A
- MCRB N/A
- EPS Growth
- MED N/A
- MCRB N/A
- EPS
- MED 0.19
- MCRB 0.00
- Revenue
- MED $602,463,000.00
- MCRB N/A
- Revenue This Year
- MED N/A
- MCRB N/A
- Revenue Next Year
- MED $2.10
- MCRB N/A
- P/E Ratio
- MED $68.61
- MCRB $785.83
- Revenue Growth
- MED N/A
- MCRB N/A
- 52 Week Low
- MED $12.87
- MCRB $0.54
- 52 Week High
- MED $36.30
- MCRB $1.53
- Technical
- Relative Strength Index (RSI)
- MED 37.76
- MCRB 43.45
- Support Level
- MED $12.87
- MCRB $0.67
- Resistance Level
- MED $13.71
- MCRB $0.76
- Average True Range (ATR)
- MED 0.51
- MCRB 0.05
- MACD
- MED -0.05
- MCRB -0.00
- Stochastic Oscillator
- MED 9.78
- MCRB 18.85
About MED MEDIFAST INC
Medifast Inc is a old health and wellness company known for its habit-based and coach-guided lifestyle solution OPTAVIA, which provides people with a simple, yet comprehensive approach to address obesity and support a healthy life. OPTAVIA provides unparalleled coaching support along with community, tailored nutrition and healthy habits, and empowers people to master their weight loss journey through each stage of life. The company has access to GLP-1 medications where clinically appropriate. Medifast remains committed to its mission of offering Lifelong Transformation, Making a Healthy Lifestyle Second Nature.
About MCRB Seres Therapeutics Inc.
Seres Therapeutics Inc is a microbiome therapeutics platform company operating in the United States. The company is engaged in developing biological drugs which are referred as ecobiotic microbiome therapeutics. The drugs discovered by the company are designed to restore health by repairing the function of a dysbiotic microbiome. The company focuses on implementing its microbiome therapeutics platform to develop ecobiotic microbiome therapeutics that treat dysbiosis in the colonic microbiome. SER-109, the company's product, is designed to prevent further recurrences of Clostridium difficile infection (CDI), a debilitating infection of the colon. In addition, the company is involved in developing SER-262, SER-287, and SER-401.